Nutritional management in newborn babies receiving therapeutic hypothermia: two retrospective observational studies using propensity score matching.
BACTEREMIA
BREAST FEEDING
ENTERAL NUTRITION
ENTEROCOLITIS, NECROTIZING
HUMANS
HYPOTHERMIA, INDUCED
HYPOXIA-ISCHAEMIA, BRAIN
INFANT, NEWBORN
MILK, HUMAN
NNRD
PARENTERAL NUTRITION
PROPENSITY SCORE
RETROSPECTIVE STUDIES
UNITED KINGDOM
Journal
Health technology assessment (Winchester, England)
ISSN: 2046-4924
Titre abrégé: Health Technol Assess
Pays: England
ID NLM: 9706284
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
entrez:
7
6
2021
pubmed:
8
6
2021
medline:
26
10
2021
Statut:
ppublish
Résumé
Therapeutic hypothermia is standard of care for babies with moderate to severe hypoxic-ischaemic encephalopathy. There is limited evidence to inform provision of nutrition during hypothermia. To assess the association during therapeutic hypothermia between (1) enteral feeding and outcomes, such as necrotising enterocolitis and (2) parenteral nutrition and outcomes, such as late-onset bloodstream infection. A retrospective cohort study using data held in the National Neonatal Research Database and applying propensity score methodology to form matched groups for analysis. NHS neonatal units in England, Wales and Scotland. Babies born at ≥ 36 gestational weeks between 1 January 2010 and 31 December 2017 who received therapeutic hypothermia for 72 hours or who died during treatment. Enteral feeding analysis - babies who were enterally fed during therapeutic hypothermia (intervention) compared with babies who received no enteral feeds during therapeutic hypothermia (control). Parenteral nutrition analysis - babies who received parenteral nutrition during therapeutic hypothermia (intervention) compared with babies who received no parenteral nutrition during therapeutic hypothermia (control). Primary outcomes were severe and pragmatically defined necrotising enterocolitis (enteral feeding analysis) and late-onset bloodstream infection (parenteral nutrition analysis). Secondary outcomes were survival at neonatal discharge, length of neonatal stay, breastfeeding at discharge, onset of breastfeeding, time to first maternal breast milk, hypoglycaemia, number of days with a central line in situ, duration of parenteral nutrition, time to full enteral feeds and growth. A total of 6030 babies received therapeutic hypothermia. Thirty-one per cent of babies received enteral feeds and 25% received parenteral nutrition. Seven babies (0.1%) were diagnosed with severe necrotising enterocolitis, and further comparative analyses were not conducted on this outcome. A total of 3236 babies were included in the matched enteral feeding analysis. Pragmatically defined necrotising enterocolitis was rare in both groups (0.5% vs. 1.1%) and was lower in babies who were fed during hypothermia (rate difference -0.5%, 95% confidence interval -1.0% to -0.1%; Propensity score methodology can address imbalances in observed confounders only. Residual confounding by unmeasured or poorly recorded variables cannot be ruled out. We did not analyse by type or volume of enteral or parenteral nutrition. Necrotising enterocolitis is rare in babies receiving therapeutic hypothermia, and the introduction of enteral feeding is associated with a lower risk of pragmatically defined necrotising enterocolitis and other beneficial outcomes, including rates of higher survival and breastfeeding at discharge. Receipt of parenteral nutrition during therapeutic hypothermia is associated with a higher rate of late-onset infection but lower mortality. These results support introduction of enteral feeding during therapeutic hypothermia. Randomised trials to assess parenteral nutrition during therapeutic hypothermia. Current Controlled Trials ISRCTN474042962. This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Every year, approximately 1200 babies in the UK suffer a lack of oxygen to the brain around birth. This is called hypoxic–ischaemic encephalopathy and can lead to brain injury or death. To treat hypoxic–ischaemic encephalopathy, babies receive cooling treatment in which their body temperature is lowered. Doctors do not know the best way to give nutrition to babies receiving cooling treatment. Babies can either be fed milk into their stomach (enteral nutrition) or be given nutrients through their veins (parenteral nutrition). We compared babies who were fed milk while they were being cooled with babies from whom milk was withheld while they were being cooled to see if there was a difference in the frequency of necrotising enterocolitis, a severe gut disease. In addition, we compared babies who received parenteral nutrition while they were being cooled with babies who did not to see if there was a difference in infections. Finally, we looked at other outcomes, including survival and breastfeeding. We used the National Neonatal Research Database, which holds de-identified (i.e. no baby can be identified) information on all babies who have received NHS neonatal care. We used a statistical approach to match babies in each group (i.e. fed babies and not fed babies) as closely as possible so that any difference in outcomes was because of different nutrition and not because of other differences. We included > 6000 babies with hypoxic–ischaemic encephalopathy. Approximately one in three babies received milk feeds and one in four babies received parenteral nutrition during cooling. Necrotising enterocolitis was very rare. More babies who were fed milk during cooling had good outcomes (e.g. being breastfed at discharge) and fewer had necrotising enterocolitis. Most of these babies received only a small amount of milk in the first 3 days. More babies given parenteral nutrition had infections, but also more survived. This suggests that it is probably safe and may be beneficial to feed babies milk during cooling. More research should look at milk feeding and parenteral nutrition during cooling.
Sections du résumé
BACKGROUND
Therapeutic hypothermia is standard of care for babies with moderate to severe hypoxic-ischaemic encephalopathy. There is limited evidence to inform provision of nutrition during hypothermia.
OBJECTIVES
To assess the association during therapeutic hypothermia between (1) enteral feeding and outcomes, such as necrotising enterocolitis and (2) parenteral nutrition and outcomes, such as late-onset bloodstream infection.
DESIGN
A retrospective cohort study using data held in the National Neonatal Research Database and applying propensity score methodology to form matched groups for analysis.
SETTING
NHS neonatal units in England, Wales and Scotland.
PARTICIPANTS
Babies born at ≥ 36 gestational weeks between 1 January 2010 and 31 December 2017 who received therapeutic hypothermia for 72 hours or who died during treatment.
INTERVENTIONS
Enteral feeding analysis - babies who were enterally fed during therapeutic hypothermia (intervention) compared with babies who received no enteral feeds during therapeutic hypothermia (control). Parenteral nutrition analysis - babies who received parenteral nutrition during therapeutic hypothermia (intervention) compared with babies who received no parenteral nutrition during therapeutic hypothermia (control).
OUTCOME MEASURES
Primary outcomes were severe and pragmatically defined necrotising enterocolitis (enteral feeding analysis) and late-onset bloodstream infection (parenteral nutrition analysis). Secondary outcomes were survival at neonatal discharge, length of neonatal stay, breastfeeding at discharge, onset of breastfeeding, time to first maternal breast milk, hypoglycaemia, number of days with a central line in situ, duration of parenteral nutrition, time to full enteral feeds and growth.
RESULTS
A total of 6030 babies received therapeutic hypothermia. Thirty-one per cent of babies received enteral feeds and 25% received parenteral nutrition. Seven babies (0.1%) were diagnosed with severe necrotising enterocolitis, and further comparative analyses were not conducted on this outcome. A total of 3236 babies were included in the matched enteral feeding analysis. Pragmatically defined necrotising enterocolitis was rare in both groups (0.5% vs. 1.1%) and was lower in babies who were fed during hypothermia (rate difference -0.5%, 95% confidence interval -1.0% to -0.1%;
LIMITATIONS
Propensity score methodology can address imbalances in observed confounders only. Residual confounding by unmeasured or poorly recorded variables cannot be ruled out. We did not analyse by type or volume of enteral or parenteral nutrition.
CONCLUSIONS
Necrotising enterocolitis is rare in babies receiving therapeutic hypothermia, and the introduction of enteral feeding is associated with a lower risk of pragmatically defined necrotising enterocolitis and other beneficial outcomes, including rates of higher survival and breastfeeding at discharge. Receipt of parenteral nutrition during therapeutic hypothermia is associated with a higher rate of late-onset infection but lower mortality. These results support introduction of enteral feeding during therapeutic hypothermia.
FUTURE WORK
Randomised trials to assess parenteral nutrition during therapeutic hypothermia.
TRIAL REGISTRATION
Current Controlled Trials ISRCTN474042962.
FUNDING
This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in
Every year, approximately 1200 babies in the UK suffer a lack of oxygen to the brain around birth. This is called hypoxic–ischaemic encephalopathy and can lead to brain injury or death. To treat hypoxic–ischaemic encephalopathy, babies receive cooling treatment in which their body temperature is lowered. Doctors do not know the best way to give nutrition to babies receiving cooling treatment. Babies can either be fed milk into their stomach (enteral nutrition) or be given nutrients through their veins (parenteral nutrition). We compared babies who were fed milk while they were being cooled with babies from whom milk was withheld while they were being cooled to see if there was a difference in the frequency of necrotising enterocolitis, a severe gut disease. In addition, we compared babies who received parenteral nutrition while they were being cooled with babies who did not to see if there was a difference in infections. Finally, we looked at other outcomes, including survival and breastfeeding. We used the National Neonatal Research Database, which holds de-identified (i.e. no baby can be identified) information on all babies who have received NHS neonatal care. We used a statistical approach to match babies in each group (i.e. fed babies and not fed babies) as closely as possible so that any difference in outcomes was because of different nutrition and not because of other differences. We included > 6000 babies with hypoxic–ischaemic encephalopathy. Approximately one in three babies received milk feeds and one in four babies received parenteral nutrition during cooling. Necrotising enterocolitis was very rare. More babies who were fed milk during cooling had good outcomes (e.g. being breastfed at discharge) and fewer had necrotising enterocolitis. Most of these babies received only a small amount of milk in the first 3 days. More babies given parenteral nutrition had infections, but also more survived. This suggests that it is probably safe and may be beneficial to feed babies milk during cooling. More research should look at milk feeding and parenteral nutrition during cooling.
Autres résumés
Type: plain-language-summary
(eng)
Every year, approximately 1200 babies in the UK suffer a lack of oxygen to the brain around birth. This is called hypoxic–ischaemic encephalopathy and can lead to brain injury or death. To treat hypoxic–ischaemic encephalopathy, babies receive cooling treatment in which their body temperature is lowered. Doctors do not know the best way to give nutrition to babies receiving cooling treatment. Babies can either be fed milk into their stomach (enteral nutrition) or be given nutrients through their veins (parenteral nutrition). We compared babies who were fed milk while they were being cooled with babies from whom milk was withheld while they were being cooled to see if there was a difference in the frequency of necrotising enterocolitis, a severe gut disease. In addition, we compared babies who received parenteral nutrition while they were being cooled with babies who did not to see if there was a difference in infections. Finally, we looked at other outcomes, including survival and breastfeeding. We used the National Neonatal Research Database, which holds de-identified (i.e. no baby can be identified) information on all babies who have received NHS neonatal care. We used a statistical approach to match babies in each group (i.e. fed babies and not fed babies) as closely as possible so that any difference in outcomes was because of different nutrition and not because of other differences. We included > 6000 babies with hypoxic–ischaemic encephalopathy. Approximately one in three babies received milk feeds and one in four babies received parenteral nutrition during cooling. Necrotising enterocolitis was very rare. More babies who were fed milk during cooling had good outcomes (e.g. being breastfed at discharge) and fewer had necrotising enterocolitis. Most of these babies received only a small amount of milk in the first 3 days. More babies given parenteral nutrition had infections, but also more survived. This suggests that it is probably safe and may be beneficial to feed babies milk during cooling. More research should look at milk feeding and parenteral nutrition during cooling.
Identifiants
pubmed: 34096500
doi: 10.3310/hta25360
pmc: PMC8215569
doi:
Banques de données
ISRCTN
['ISRCTN474042962']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-106Subventions
Organisme : Department of Health
ID : 16/79/03
Pays : United Kingdom
Références
N Engl J Med. 2009 Oct 1;361(14):1349-58
pubmed: 19797281
Arch Pediatr Adolesc Med. 2011 Aug;165(8):692-700
pubmed: 21464374
Lancet Child Adolesc Health. 2018 Jul;2(7):505-515
pubmed: 30169323
Lancet Gastroenterol Hepatol. 2017 Jan;2(1):43-51
pubmed: 28404014
Lancet. 2014 Jun 14;383(9934):2041-2042
pubmed: 24931684
J Neonatal Perinatal Med. 2013;6(2):125-30
pubmed: 24246514
PLoS One. 2018 Aug 16;13(8):e0201815
pubmed: 30114277
Neonatology. 2018;113(4):347-352
pubmed: 29510382
Cochrane Database Syst Rev. 2014;(12):CD001970
pubmed: 25436902
Eur J Clin Nutr. 2012 May;66(5):639-44
pubmed: 22252109
Dev Med Child Neurol. 2018 Sep;60(9):906-913
pubmed: 29023666
BMJ Open. 2018 Oct 23;8(10):e026739
pubmed: 30355795
Pediatrics. 2012 May;129(5):e1260-8
pubmed: 22492770
Arch Dis Child Fetal Neonatal Ed. 2015 Nov;100(6):F541-52
pubmed: 26063194
JAMA Pediatr. 2017 Mar 1;171(3):256-263
pubmed: 28046187
Evid Rep Technol Assess (Full Rep). 2007 Apr;(153):1-186
pubmed: 17764214
J Matern Fetal Neonatal Med. 2012 Apr;25 Suppl 1:125-7
pubmed: 22320395
Pediatr Neurol. 2005 Jan;32(1):18-24
pubmed: 15607599
BMC Pregnancy Childbirth. 2019 Dec 30;19(1):528
pubmed: 31888523
Acta Paediatr. 2015 Feb;104(2):146-51
pubmed: 25348803
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
BMJ Paediatr Open. 2017 Jul 26;1(1):e000022
pubmed: 29637095
N Engl J Med. 2011 Aug 11;365(6):506-17
pubmed: 21714640
Arch Dis Child Fetal Neonatal Ed. 2018 Jul;103(4):F388-F390
pubmed: 28942433
BMJ. 2018 Nov 28;363:k4738
pubmed: 30487232
N Engl J Med. 2016 Mar 24;374(12):1111-22
pubmed: 26975590
Lancet. 2016 Feb 13;387(10019):649-660
pubmed: 26628328